Policy Misalignment Is Harming AI Development, Experts Say
Experts lamented the lack of consensus standards for AI medical devices, which they said could pose harm to innovators.
You may also be interested in...
Speaking at the Consumer Electronics Show, FDA commissioner says agency and industry must work together to understand AI/ML and continuously assess the algorithms for efficacy.
Health equity by design should be a core principle of AI/ML development, a national health IT official told the US Congress during Global Health Equity Week.
Are ‘regulatory sandboxes’ the answer to addressing complexities that will inevitably arise when the EU’s AI Act has been adopted and overlaps with the EU’s medtech regulations? This topic was examined by the European Commission at the recent International Medical Device Regulators Forum in Berlin.